NEW YORK (Reuters Health)—Tofacitinib is better than placebo (and noninferior to etanercept) for treating patients with moderate-to-severe chronic plaque psoriasis, according to Pfizer’s OPT Compare trial. In an earlier 12-week, phase 2b, dose-ranging trial, the oral JAK inhibitor tofacitinib proved to be more effective than placebo for treating patients with moderate-to-severe plaque psoriasis. Based on…
Search results for: hip OA
Pediatric to Adult Care Transition Challenging for Patients with JIA
Dr. Sheffield is an adult rheumatologist who received the following referral request from a family doctor: “Please see this 22-year-old male with a history of juvenile arthritis for ongoing care. I have only seen him once, and have no previous medical records.” Dr. Sheffield meets with Paul, who reports that he has had arthritis since…
The ACR, Rheumatologists Advance Issues Through Advocacy
Rheumatologists and rheumatology health professionals make a difference every day in the lives of patients. And through the work of many devoted members, the College takes that commitment beyond the care setting and into the policy arena to Advance Rheumatology! on Capitol Hill and in state capitols across the country. I want to take a…
Physicians as Targets of Medical Workplace Violence
Tuesday, Jan. 20, a busy morning lay ahead for the staff of the cardiovascular surgery clinic. There were several new patients to see. No doubt, many of them were anxious to hear whether the skills of the surgeons they were going to meet could help them live another day. There were countless follow-up visits and…
Rheumatologist Recalls Personal Experience with RA
In late March 2012, I awoke with pain in my left hand. I had difficulty moving my metacarpophalangeal (MCP) joints. They did not move smoothly, but clunked. As I repeatedly attempted to open and close my hand, I realized that I had morning stiffness. As the pain and stiffness gradually improved over the next hour,…
Rheumatology Research Foundation Hits 30-Year Milestone
At the 2014 ACR/ARHP Annual Meeting in Boston, the Rheumatology Research Foundation staff sat down with a few ACR and ARHP members to get their take on what the Foundation’s 30th anniversary means to them. We spoke with current and former leaders of the Foundation and the ACR, as well as numerous Foundation award recipients,…
RheumPAC: How the ACR’s Non-Partisan Political Action Committee Works
The classic American social studies lesson is How a Bill Becomes a Law, but a more pertinent lesson for U.S. rheumatologists today may be How a Dollar Bill Becomes a PAC. This article is a nuts-and-bolts primer on how exactly RheumPAC works. The purpose is to inform readers about how and why to participate. Money…
Rheumatologists Expand Reach Through Telemedicine
What started out as a way to bring specialty medicine to rural areas around 40 years ago has evolved from sharing imaging and laboratory results to seeing and interacting with patients remotely. Telemedicine is beginning to evolve from its traditional urban–rural linkage, and rheumatologists are following along. “Telemedicine covers a variety of services, but it…
Psoriatic Arthritis: Recognize, Manage Comorbidities
As the literature on comorbidities linked to psoriatic arthritis (PsA) expands, it’s becoming more difficult for clinicians to keep up with what comorbidities should be assessed and how these comorbidities affect treatment selection. Given this, rheumatologists at the Perelman School of Medicine at University of Pennsylvania, Cleveland Clinic and Hospital for Special Surgery in New…
Tips for Physicians on Handling Personal Problems at Work
As a physician, it’s important to be in the present 100% of the time. “Writing the wrong number on a prescription pad is an extreme, but important, example of what could happen if a physician is distracted,” says consultant Donna Singer, Donna Singer Consulting LLC, Newton, Mass. Sanjay Chabra, DO, director of rheumatology, St. Jude…
- « Previous Page
- 1
- …
- 243
- 244
- 245
- 246
- 247
- …
- 331
- Next Page »